Brief: Sanofi Expands Collaboration With SK Bioscience

SK Bioscience Co

23/12/2024 06:21

Dec 23 (Reuters) - Sanofi SA  SASY.PA :
    * SANOFI INITIATES PHASE 3 PROGRAM FOR PCV21 AND EXPANDS
COLLABORATION WITH SK BIOSCIENCE FOR NEXT-GENERATION
PNEUMOCOCCAL CONJUGATE VACCINES
    * PCV21 FIRST VACCINE WITH 20+ SEROTYPES TO ENTER PHASE 3
    * TO COMMERCIALIZE VACCINES WORLDWIDE EXCEPT SOUTH KOREA
    * TO PAY EUR 50M UPFRONT TO SK BIOSCIENCE

Source text:  urn:newsml:reuters.com:*:nGNE5bk0dN
Further company coverage:  SASY.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))